{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,16]],"date-time":"2026-03-16T21:10:25Z","timestamp":1773695425735,"version":"3.50.1"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2007,7,11]],"date-time":"2007-07-11T00:00:00Z","timestamp":1184112000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Calcif Tissue Int"],"published-print":{"date-parts":[[2007,8,2]]},"DOI":"10.1007\/s00223-007-9041-1","type":"journal-article","created":{"date-parts":[[2007,7,16]],"date-time":"2007-07-16T17:35:24Z","timestamp":1184607324000},"page":"99-106","source":"Crossref","is-referenced-by-count":8,"title":["Effect of L-Carnitine Supplementation on Secondary Hyperparathyroidism and Bone Metabolism in Hemodialyzed Patients"],"prefix":"10.1007","volume":"81","author":[{"given":"Roman","family":"Cibulka","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jaroslav","family":"Racek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard","family":"Pikner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel","family":"Rajdl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ladislav","family":"Trefil","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eugenie","family":"Vesela","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marie","family":"Studenovska","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Romana","family":"Siroka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2007,7,11]]},"reference":[{"key":"9041_CR1","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1161\/01.RES.77.4.726","volume":"77","author":"BO Schonekess","year":"1995","unstructured":"Schonekess BO, Allard MF, Lopaschuk GD (1995) Propionyl L-carnitine improvement of hypertrophied heart function is accompanied by an increase in carbohydrate oxidation. Circ Res 77:726\u2013734","journal-title":"Circ Res"},{"key":"9041_CR2","first-page":"14","volume":"19","author":"FM Vaz","year":"2002","unstructured":"Vaz FM, Wanders R (2002) Carnitine homeostasis and human disease: advances in metabolite analysis. LabMedica 19:14\u201317","journal-title":"LabMedica"},{"key":"9041_CR3","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1016\/S0140-6736(78)90714-6","volume":"1","author":"PA Battistella","year":"1978","unstructured":"Battistella PA, Angelini C, Vergani L, Bertoli M, Lorenzi S (1978) Carnitine deficiency induced during hemodialysis. Lancet 1:939","journal-title":"Lancet"},{"key":"9041_CR4","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/S0140-6736(78)90422-1","volume":"1","author":"T Bohmer","year":"1978","unstructured":"Bohmer T, Bergrem H, Eiklid K (1978) Carnitine deficiency induced during intermittent haemodialysis for renal failure. Lancet 1:126\u2013128","journal-title":"Lancet"},{"key":"9041_CR5","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1067\/mcp.2000.108850","volume":"68","author":"AM Evans","year":"2000","unstructured":"Evans AM, Faull R, Fornasini G, Lemanowicz EF, Longo A, Pace S, Nation RL (2000) Pharmacokinetics of L-carnitine in patients with end-stage renal disease undergoing long-term hemodialysis. Clin Pharmacol Ther 68:238\u2013249","journal-title":"Clin Pharmacol Ther"},{"key":"9041_CR6","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1536\/ihj.23.349","volume":"23","author":"Y Suzuki","year":"1982","unstructured":"Suzuki Y, Nariata M, Yamazaki N (1982) Effects of L-carnitine on arrhythmias during hemodialysis. Jpn Heart J 23:349\u2013359","journal-title":"Jpn Heart J"},{"key":"9041_CR7","first-page":"530","volume":"30","author":"S Goral","year":"2001","unstructured":"Goral S (2001) Levocarnitine\u2019s role in the treatment of patients with end-stage renal disease: a review. Dial Transplant 30:530\u2013538","journal-title":"Dial Transplant"},{"issue":"suppl 5","key":"9041_CR8","doi-asserted-by":"crossref","first-page":"V2","DOI":"10.1093\/ndt\/gfh1049","volume":"19","author":"WH Horl","year":"2004","unstructured":"Horl WH (2004) The clinical consequences of secondary hyperparathyroidism: focus on clinical outcomes. Nephrol Dial Translpant 19(suppl 5):V2\u2013V8","journal-title":"Nephrol Dial Translpant"},{"key":"9041_CR9","doi-asserted-by":"crossref","first-page":"1494","DOI":"10.1172\/JCI114043","volume":"83","author":"AA Portale","year":"1989","unstructured":"Portale AA, Halloran BP, Morris RC Jr (1989) Physiologic regulation of the serum concentration of 1,25-dihydroxyvitamin D3 by phosphorus in normal men. J Clin Invest 83:1494\u20131499","journal-title":"J Clin Invest"},{"key":"9041_CR10","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.1172\/JCI111365","volume":"73","author":"AA Portale","year":"1984","unstructured":"Portale AA, Booth BE, Halloran BP, Morris RC Jr (1984) Effect of dietary phosphorus on circulating concentrations of 1,25-dihydroxyvitamin D and immunoreactive parathyroid hormone in children with moderate renal insufficiency. J Clin Invest 73:1580\u20131589","journal-title":"J Clin Invest"},{"key":"9041_CR11","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1038\/ki.1994.408","volume":"46","author":"C Combe","year":"1994","unstructured":"Combe C, Aparicio M (1994) Phosphorus and protein restriction and parathyroid function in chronic renal failure. Kidney Int 46:1381\u20131386","journal-title":"Kidney Int"},{"issue":"suppl 2","key":"9041_CR12","doi-asserted-by":"crossref","first-page":"S54","DOI":"10.1053\/ajkd.2001.20740","volume":"37","author":"E Slatopolsky","year":"2001","unstructured":"Slatopolsky E, Brown A, Dusso A (2001) Role of phosphorus in the pathogenesis of secondary hyperparathyroidism. Am J Kidney Dis 37(suppl 2):S54\u2013S57","journal-title":"Am J Kidney Dis"},{"key":"9041_CR13","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1042\/bj2480129","volume":"248","author":"G Adamek","year":"1987","unstructured":"Adamek G, Felix R, Guenther HL, Fleisch H (1987) Fatty acid oxidation in bone tissue and bone cells in culture. Characterization and hormonal influences. Biochem J 248:129\u2013137","journal-title":"Biochem J"},{"key":"9041_CR14","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1038\/ki.1990.290","volume":"38","author":"S Ahmad","year":"1990","unstructured":"Ahmad S, Robertson HT, Golper TA, Wolfson M, Kurtin P, Katz LA, Hirschberg R, Nicora R, Ashbrook DW, Kopple JD (1990) Multicenter trial of L-carnitine in maintenance hemodialysis patients. II. Clinical and biochemical effects. Kidney Int 38:912\u2013918","journal-title":"Kidney Int"},{"key":"9041_CR15","unstructured":"Nakazawa R, Furuhashi S, Shioda T, Kawamura K, Kimura K, Azuma N, Suzuki M (2002) Effect of long-term L-carnitine supplementation on hyperphosphatemic hemodialysis patients [abstract]. Presented at the 11th International Congress on Nutrition and Metabolism in Renal Disease, Nagoya, Japan, March 29\u201331, 2002"},{"key":"9041_CR16","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1159\/000045993","volume":"88","author":"E Vesela","year":"2001","unstructured":"Vesela E, Racek J, Trefil L, Jankov\u00fdch V, Pojer M (2001) Effect of L-carnitine supplementation in hemodialysis patients. Nephron 88:218\u2013223","journal-title":"Nephron"},{"key":"9041_CR17","doi-asserted-by":"crossref","first-page":"5050","DOI":"10.1210\/endo.142.12.8536","volume":"142","author":"S Khosla","year":"2001","unstructured":"Khosla S (2001) The OPG\/RANKL\/RANK system. Endocrinology 142:5050\u20135055","journal-title":"Endocrinology"},{"key":"9041_CR18","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1016\/j.coph.2005.06.005","volume":"5","author":"PJ Kostenuik","year":"2005","unstructured":"Kostenuik PJ (2005) Osteoprotegerin and RANKL regulate bone resorption, density, geometry and strength. Curr Opin Pharmacol 5:618\u2013625","journal-title":"Curr Opin Pharmacol"},{"key":"9041_CR19","unstructured":"Seim H (1998) Carnitine. In: Lothar T (ed), Clinical Laboratory Diagnostics. TH-Books Verlagsgesellschaft, Frankfurt, 202\u2013207"},{"issue":"suppl 3","key":"9041_CR20","first-page":"S1","volume":"42","author":"National Kidney Foundation","year":"2003","unstructured":"National Kidney Foundation (2003) Kidney Disease Quality Outcomes Initiative (K\/DOQI) clinical practice guidelines. Bone metabolism and disease in chronic kidney disease. Am J Kidney Dis 42(suppl 3):S1\u2013S201","journal-title":"Am J Kidney Dis"},{"issue":"suppl 5","key":"9041_CR21","doi-asserted-by":"crossref","first-page":"V15","DOI":"10.1093\/ndt\/gfh1051","volume":"19","author":"F Locatelli","year":"2004","unstructured":"Locatelli F (2004) The need for better control of secondary hyperparathyroidism. Nephrol Dial Translpant 19(suppl 5):V15\u2013V19","journal-title":"Nephrol Dial Translpant"},{"issue":"suppl 22","key":"9041_CR22","first-page":"S116","volume":"32","author":"G Guarnieri","year":"1987","unstructured":"Guarnieri G, Toigo G, Crapesi L, Situlin R, Del Bianco MA, Corsi M, LoGreco P, Paviotti G, Mioni G, Campanacci L (1987) Carnitine metabolism in chronic renal failure. Kidney Int 32(suppl 22):S116\u2013S127","journal-title":"Kidney Int"},{"key":"9041_CR23","doi-asserted-by":"crossref","first-page":"2141","DOI":"10.1046\/j.1523-1755.1999.00461.x","volume":"55","author":"P Urena","year":"1999","unstructured":"Urena P, De Vernejoul MC (1999) Circulating biochemical markers of bone remodeling in uremic patients. Kidney Int 55:2141\u20132156","journal-title":"Kidney Int"},{"key":"9041_CR24","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1053\/j.ajkd.2003.12.003","volume":"43","author":"KJ Martin","year":"2004","unstructured":"Martin KJ, Olgaard K; Bone Turnover Work Group (2004) Diagnosis, assessment, and treatment of bone turnover abnormalities in renal osteodystrophy. Am J Kidney Dis 43:558\u2013565","journal-title":"Am J Kidney Dis"},{"key":"9041_CR25","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1210\/jcem-63-4-892","volume":"63","author":"SA Charhon","year":"1986","unstructured":"Charhon SA, Delmas PD, Malaval L, Chavassieux PM, Arlot M, Chapuy MC, Meunier PJ (1986) Serum bone Gla-protein in renal osteodystrophy: comparison with bone histomorphometry. J Clin Endocrinol Metab 63:892\u2013897","journal-title":"J Clin Endocrinol Metab"},{"key":"9041_CR26","first-page":"21","volume":"2","author":"JL Sebert","year":"1987","unstructured":"Sebert JL, Ruiz JC, Fournier A, Fardellone P, Gueris J, Marie A, Moriniere P, Codet MP, Renaud H (1987) Plasma bone Gla-protein: assessment of its clinical value as an index of bone formation in hemodialyzed patients. Bone Miner 2:21\u201327","journal-title":"Bone Miner"},{"key":"9041_CR27","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/S0092-8674(00)80209-3","volume":"89","author":"WS Simonet","year":"1997","unstructured":"Simonet WS, Lacey DL, Dunstan CR, Kelley M, Chang MS, Luthy R, Nguyen HQ, Wooden S, Bennett L, Boone T, Shimamoto G, DeRose M, Elliott R, Colombero A, Tan HL, Trail G, Sullivan J, Davy E, Bucay N, Renshaw-Gegg L, Hughes TM, Hill D, Pattison W, Campbell P, Sander S, Van G, Tarpley J, Derby P, Lee R, Boyle WJ (1997) Osteoprotegerin: a novel secreted protein involved in the regulation of bone density. Cell 89:309\u2013319","journal-title":"Cell"},{"key":"9041_CR28","doi-asserted-by":"crossref","first-page":"c1","DOI":"10.1159\/000081787","volume":"99","author":"SJ Steddon","year":"2005","unstructured":"Steddon SJ, Fan SL, Cunningham J (2005) New prospects for the management of renal bone disease. Nephron Clin Pract 99:c1\u2013c7","journal-title":"Nephron Clin Pract"},{"key":"9041_CR29","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1359\/jbmr.2001.16.2.348","volume":"16","author":"PJ Bekker","year":"2001","unstructured":"Bekker PJ, Holloway D, Nakanishi A, Arrighi M, Leese PT, Dunstan CR (2001) The effect of a single dose of osteoprotegerin in postmenopausal women. J Bone Miner Res 16:348\u2013360","journal-title":"J Bone Miner Res"},{"key":"9041_CR30","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1007\/s00198-005-0047-0","volume":"17","author":"A Nakashima","year":"2006","unstructured":"Nakashima A, Yorioka N, Doi S, Takasugi N, Shigemoto K, Kohno N (2006) Osteoprotegerin and bone mineral density in hemodialysis patients. Osteoporos Int 17:841\u2013846","journal-title":"Osteoporos Int"},{"key":"9041_CR31","doi-asserted-by":"crossref","first-page":"1860","DOI":"10.1093\/ndt\/17.10.1860","volume":"17","author":"JJ Kazama","year":"2002","unstructured":"Kazama JJ, Kato H, Sato T, Shigematsu T, Fukagawa M, Iwasaki Y, Gejyo F (2002) Circulating osteoprotegerin is not removed through haemodialysis membrane. Nephrol Dial Transplant 17:1860\u20131861","journal-title":"Nephrol Dial Transplant"},{"key":"9041_CR32","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1515\/CCLM.2002.177","volume":"40","author":"I Avbersek-Luznik","year":"2002","unstructured":"Avbersek-Luznik I, Malesic I, Rus I, Marc J (2002) Increased levels of osteoprotegerin in hemodialysis patients. Clin Chem Lab Med 40:1019\u20131023","journal-title":"Clin Chem Lab Med"},{"key":"9041_CR33","doi-asserted-by":"crossref","first-page":"3552","DOI":"10.1210\/endo.140.8.6887","volume":"140","author":"SK Lee","year":"1999","unstructured":"Lee SK, Lorenzo JA (1999) Parathyroid hormone stimulates TRANCE and inhibits osteoprotegerin messenger ribonucleic acid expression in murine bone marrow cultures: correlation with osteoclast-like cell formation. Endocrinology 140:3552\u20133561","journal-title":"Endocrinology"},{"key":"9041_CR34","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1093\/ndt\/gfh672","volume":"20","author":"I Avbersek-Luznik","year":"2005","unstructured":"Avbersek-Luznik I, Balon BP, Rus I, Marc J (2005) Increased bone resorption in HD patients: is it caused by elevated RANKL synthesis? Nephrol Dial Transplant 20:566\u2013570","journal-title":"Nephrol Dial Transplant"},{"key":"9041_CR35","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1007\/s00223-004-0147-4","volume":"76","author":"S Colucci","year":"2005","unstructured":"Colucci S, Mori G, Vaira S, Brunetti G, Greco G, Mancini L, Simone GM, Sardelli F, Koverech A, Zallone A, Grano M (2005) L-Carnitine and isovaleryl L-carnitine fumarate positively affect human osteoblast proliferation and differentiation in vitro. Calcif Tissue Int 76:458\u2013465","journal-title":"Calcif Tissue Int"}],"container-title":["Calcified Tissue International"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00223-007-9041-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00223-007-9041-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00223-007-9041-1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,24]],"date-time":"2019-05-24T07:37:52Z","timestamp":1558683472000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00223-007-9041-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,7,11]]},"references-count":35,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2007,8,2]]}},"alternative-id":["9041"],"URL":"https:\/\/doi.org\/10.1007\/s00223-007-9041-1","relation":{},"ISSN":["0171-967X","1432-0827"],"issn-type":[{"value":"0171-967X","type":"print"},{"value":"1432-0827","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,7,11]]}}}